Steris

STE · Health Care · Market cap $22.4B

Q4 FY26 Jan 1 – Mar 31, 2026 reported May 29, 2026

Revenue$1.6B +7% year over year

Gross profit$0.7B

Operating profit$0.3B

Net profit$0.2B 14% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q4 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	1.6	100%	+7%
Healthcare Segment	1.1	69%	+7%
Applied Sterilization Technologies	0.3	19%	+6%
Life Science Member	0.2	12%	+9%
Cost of revenue	−0.9	56%
Gross profit	0.7	44% margin	+1pp
Research & development	−0	2%	+0pp
SG&A	−0.4	22%	+0pp
Operating profit	0.3	20% margin	+5pp
Tax	−0.1
Net profit	0.2	14%	+4pp

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.5	100%	+9%
Healthcare Segment	1.1	73%	+9%
Applied Sterilization Technologies	0.3	20%	+11%
Life Science	0.1	7%	+7%
Cost of revenue	−0.8	53%
Gross profit	0.7	44% margin	−1pp
Research & development	−0	2%	+0pp
SG&A	−0.4	24%	−1pp
Operating profit	0.3	18% margin	+0pp
Tax	−0.1
Net profit	0.2	13%	+0pp

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.5	100%	+10%
Healthcare	1	67%	+9%
Applied Sterilization Technologies	0.3	20%	+10%
Life Science	0.1	7%	+13%
Cost of revenue	−0.8	53%
Gross profit	0.6	44% margin	+1pp
Research & development	−0	2%	+0pp
SG&A	−0.4	24%	−1pp
Operating profit	0.3	18% margin	+2pp
Tax	−0.1
Net profit	0.2	13%	+2pp

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Mar 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	1.5	100%	+4%
Healthcare Segment	1.1	73%	+5%
Applied Sterilization Technologies	0.3	20%	+9%
Life Science Member	0.1	7%	−7%
Cost of revenue	−0.8	53%
Gross profit	0.6	43% margin	+2pp
Research & development	−0	2%	+0pp
SG&A	−0.3	23%	+0pp
Other	−0.1	4%	+0pp
Operating profit	0.2	15% margin	+0pp
Tax	−0.1
Net profit	0.1	10%	+10pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q4 FY26	Jan 1 – Mar 31, 2026	May 29, 2026	$1.6B	+7%	19%	$0.2B	14%
Q3 FY26	Dec 31, 2025	Feb 6, 2026	$1.5B	+9%	20%	$0.2B	13%
Q2 FY26	Jul 1 – Sep 30, 2025	Nov 6, 2025	$1.5B	+10%	20%	$0.2B	13%
Q4 FY25	Jan 1 – Mar 31, 2025	May 29, 2025	$1.5B	+4%	13%	$0.1B	10%